38 results on '"Glueck, Reinhard"'
Search Results
2. Immunogenicity of next-generation HPV vaccines in non-human primates: Measles-vectored HPV vaccine versus Pichia pastoris recombinant protein vaccine
3. Safety and Immunogenicity of Intranasally Administered Inactivated Trivalent Virosome-Formulated Influenza Vaccine Containing Escherichia coli Heat-Labile Toxin as a Mucosal Adjuvant
4. Rapid emergence of a viral resistant mutant in WHV chronically infected woodchucks treated with lamivudine and a pre-S/S CHO-derived hepatitis B virus vaccine
5. Attenuated measles virus as a vaccine vector
6. A pre-S/S CHO-derived hepatitis B virus vaccine protects woodchucks from WHV productive infection
7. Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch
8. Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine
9. Immunogenicity and safety of a novel IL-2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residents
10. An open-label comparison of the immunogenicity and tolerability of intranasal and intramuscular formulations of virosomal influenza vaccine in healthy adults
11. Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization
12. Review of intranasal influenza vaccine
13. Perspectives: towards a peptide-based vaccine against hepatitis C virus
14. Intranasal Immunization with Mumps Virus DNA Vaccine Delivered by Influenza Virosomes Elicits Mucosal and Systemic Immunity
15. Towards clinical testing of a single-administration tetanus vaccine based on PLA/PLGA microspheres
16. Efficient vaccination by intradermal or intramuscular inoculation of plasmid DNA expressing hepatitis B surface antigen under desmin promoter/enhancer control
17. Adjuvant activity of immunopotentiating reconstituted influenza virosomes (IRIVs)
18. Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy adults ≥ 18 years of age: A randomized, multicenter, phase II / III clinical trial.
19. Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis.
20. Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial
21. HPV vaccines: Global perspectives.
22. Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant.
23. Tolerance and immunogenicity of the simultaneous administration of virosome hepatitis A and yellow fever vaccines.
24. Immunogenicity of IRIV- versus alum-adjuvanted diphtheria and tetanus toxoid vaccines in influenza primed mice
25. Immune response to rabies booster vaccination in subjects who had postexposure treatment more than 5 years previously.
26. Modulation of concanavalin A-induced lymphocyte stimulation by human low-density lipoproteins.
27. ChemInform Abstract: Exploiting Conformationally Constrained Peptidomimetics and an Efficient Human-Compatible Delivery System in Synthetic Vaccine Design.
28. Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines
29. Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients
30. Safety and immunogenicity of Lyssavac Berna human diploid cell rabies vaccine in healthy adults
31. A virosome vaccine antigen delivery system does not stimulate an antiphospholipid antibody response in humans
32. Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial
33. Efficacy study of a new albumin-free Human Diploid Cell Rabies Vaccine (Lyssavac-HDC, Berna) in 100 severely rabies-exposed Thai patients
34. Interference between strains in live virus vaccines I: combined vaccination with measles, mumps and rubella vaccine
35. Safety, immunogenicity, and kinetics of the immune response to a single dose of virosome-formulated hepatitis A vaccine in Thais
36. Chapter 2.5 - “Virosomes”, a new liposome-like vaccine delivery system
37. Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma
38. New strategies to overcome the drawbacks of currently available flu vaccines.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.